Genmab AS (GMAB)
21.21
-0.46
(-2.12%)
USD |
NASDAQ |
Nov 14, 16:00
21.21
0.00 (0.00%)
After-Hours: 18:32
Genmab Total Assets (Quarterly): 5.940B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.940B |
| June 30, 2024 | 5.544B |
| March 31, 2024 | 5.306B |
| December 31, 2023 | 5.239B |
| September 30, 2023 | 4.991B |
| June 30, 2023 | 4.667B |
| March 31, 2023 | 4.449B |
| December 31, 2022 | 4.335B |
| September 30, 2022 | 4.056B |
| June 30, 2022 | 3.858B |
| March 31, 2022 | 3.739B |
| December 31, 2021 | 3.749B |
| September 30, 2021 | 3.742B |
| June 30, 2021 | 3.598B |
| March 31, 2021 | 3.501B |
| December 31, 2020 | 3.495B |
| September 30, 2020 | 3.393B |
| June 30, 2020 | 3.120B |
| March 31, 2020 | 2.260B |
| December 31, 2019 | 2.270B |
| September 30, 2019 | 1.953B |
| June 30, 2019 | 1.368B |
| March 31, 2019 | 1.313B |
| December 31, 2018 | 1.296B |
| September 30, 2018 | 1.152B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.117B |
| March 31, 2018 | 1.121B |
| December 31, 2017 | 1.064B |
| September 30, 2017 | 933.09M |
| June 30, 2017 | 927.37M |
| March 31, 2017 | 776.51M |
| December 31, 2016 | 744.93M |
| September 30, 2016 | 655.13M |
| June 30, 2016 | 617.26M |
| March 31, 2016 | 594.65M |
| December 31, 2015 | 571.65M |
| September 30, 2015 | 528.11M |
| June 30, 2015 | 493.65M |
| March 31, 2015 | 460.32M |
| December 31, 2014 | 468.04M |
| September 30, 2014 | 482.55M |
| June 30, 2014 | 497.24M |
| March 31, 2014 | 514.00M |
| December 31, 2013 | 320.49M |
| September 30, 2013 | 325.14M |
| June 30, 2013 | 292.85M |
| March 31, 2013 | 301.58M |
| December 31, 2012 | 300.05M |
| September 30, 2012 | 306.84M |
| June 30, 2012 | 237.29M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.260B
Minimum
Mar 2020
5.940B
Maximum
Sep 2024
4.063B
Average
3.803B
Median
Total Assets (Quarterly) Benchmarks
| Novo Nordisk AS | 59.53B |
| Ascendis Pharma AS | 812.82M |
| Galecto Inc | 23.38M |
| Evaxion Biotech AS | 15.18M |
| IO Biotech Inc | 111.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.159B |
| Shareholders Equity (Quarterly) | 4.781B |
| Current Ratio | 5.169 |